secwatch.observer — SEC 8-K summary
======================================

Issuer:     Skye Bioscience, Inc. (SKYE)
CIK:        0001516551
Form:       8-K
Filed at:   2025-06-11T23:59:59+00:00
Accession:  0001516551-25-000046
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 4.01, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Skye Bioscience changes auditor to CBIZ CPAs; shareholders re-elect board at annual meeting
--------------------------------------------------------------------------------

- Marcum LLP resigned as auditor June 9, 2025 after acquisition by CBIZ; CBIZ CPAs engaged for FY 2025.
- No disagreements or reportable events during fiscal years 2023-2024 and through June 9, 2025.
- At June 6 annual meeting, all 6 director nominees elected; say-on-pay approved (17.1M for, 2.7M against).
- Advisory frequency vote set to 1 year; board adopts annual say-on-pay vote policy until 2031.
- Ratification of Marcum as auditor passed with 25.4M shares for (99.8% of votes cast).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1516551/000151655125000046/0001516551-25-000046-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1516551/000151655125000046/skye-20250606.htm
  HTML page:      https://secwatch.observer/filing/0001516551-25-000046

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer